WOONSOCKET, R.I. — CVS Caremark on Tuesday announced that a month-long, in-store fundraising campaign at CVS/pharmacy locations throughout the Boston area raised more than $650,000 in donations from customers to The One Fund Boston, which was established by Massachusetts Gov. Deval Patrick and Boston Mayor Thomas Menino to raise money for victims and families who were affected by the attack on the Boston Marathon.

The in-store donation campaign at more than 260 Boston-area CVS/pharmacy stores ran from April 19 to May 11, during which customers could add $1, $3 or an amount of their choice to their purchase at the register. This fundraising follows a $100,000 donation to The One Fund Boston made by the CVS Caremark Charitable Trust, the private foundation of CVS Caremark.

"We sincerely thank all of our Boston customers who supported our in-store campaign for The One Fund Boston and generously made a donation to help victims and families recover from this tragedy," stated Larry Merlo, president and CEO of CVS Caremark. "I also want to thank our colleagues who responded quickly to launch this fundraising campaign within a few days of the Boston Marathon."

The One Fund Boston continues to accept online donations from the public at OneFundBoston.org.

Natural Squelch spray eliminates odors on skin, hair, clothes

DELRAY BEACH, Fla. — A new all-natural spray promises to not only cover up unwanted smells, but also eliminate them at the source, the company stated this week.

Squelch is an all-natural, non-toxic spray that is odorless. It is safe to use on skin, hair, clothes or any other source that may trap odors. Squelch also is hypoallergenic, does not stain or fade clothes and is environmentally friendly.

According to the company, odors can come from a variety of sources. Virtually all of these sources have common carbon molecule bonds that can cause odors. Squelch works by breaking apart these carbon bonds to eliminate the source of the odor, not just mask it, with its OdorBreak Technology.

Squelch is made with water, vegetable-based fatty acid, soybean oil, corn oil, sodium lauryl sulfate and other natural extracts. It comes in a diminutive, cylindrical tube ideal for portable use after the gym or work, or for use in the car and on the go.

Squelch will soon be available at retailers nationwide and is currently available on the company’s website. It can be purchased individually or in quantities of three, six and 12. Squelch is made in the United States.

Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

Actavis seeks FDA approval for contraceptive patch

PARSIPPANY, N.J. — The Food and Drug Administration will review an experimental contraceptive patch made by Actavis, the drug maker said Tuesday.

Actavis said the FDA accepted for review its application for norethindrone transdermal delivery system. The patch, which does not yet have a brand name, is designed to provide continuous delivery of norethindrone during a once-weekly, seven-day dosing regimen.

The company said once-weekly dosing with the patch may improve compliance and convenience in progestin-only contraceptive users and provide more consistent average levels of norethindrone in the plasma than pills.

Forgotten Password

Registration complete

REGISTER

USERNAME *

Spaces are allowed; punctuation is not allowed except for periods, hyphens, and underscores.

E-MAIL ADDRESS *

A valid e-mail address. All e-mails from the system will be sent to this address. The e-mail address is not made public and will only be used if you wish to receive a new password or wish to receive certain news or notifications by e-mail.

Password *

Confirm Password *

Please choose a password for your account; it must be 8 - 30 characters. .

First Name *

Last Name *

Company Name *

Job Title *

ZIP *

Are you a *

Retailer or Healthcare professional

Non-Retailer

How many stores do you operate?: *

Which best describes the business/industry you work in?: *

Which best describes your job title?: *

Please select the newsletters you would like to subscribe to

DSN A.M.
Daily news stories covering the retail drug industry

Breaking News
First-to-the-market with developing stories in the industry